Ebos Group has posted another record result for the 2021 financial year, announcing double-digit earnings growth, and an $80 million pet food manufacturing facility to be located in NSW.
The wholesaler and distributor of healthcare, medical and pharmaceutical products said revenue reached $9.2 billion, exceeding $9 billion for the first time, up 5 per cent for the 2021 financial year. Statutory net profit after tax jumped 14 per cent to $185.3 million.
Loading...
Carrie LaFrenz is a senior journalist covering retail/consumer goods. She previously covered healthcare/biotech. Carrie has won multiple awards for her journalism including financial journalist of the year from The National Press Club. Connect with Carrie on Twitter. Email Carrie at carrie.lafrenz@afr.com
